{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:34:36Z","timestamp":1753893276804,"version":"3.41.2"},"reference-count":25,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T00:00:00Z","timestamp":1672963200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Surg."],"abstract":"<jats:p>Subependymal Giant Cell Astrocytoma (SEGA) is a common diagnosis in patients with Tuberous Sclerosis. Although surgical treatment is often required, resection may entail a significant risk for cognitive function given the anatomical relation with critical structures such as the fornices and subgenual area. Therefore, target subtotal resections using minimal invasive approaches focused in the higher metabolic areas are valuable options to preserve quality of life while addressing specific problems caused by the tumor, such as hydrocephalus or progressive growth of a specific component of the tumor. In this report, the authors explore the potential role of 5-ALA in the identification of highly metabolic areas during SEGA resection in the context of minimal invasive approaches.<\/jats:p>","DOI":"10.3389\/fsurg.2022.1065979","type":"journal-article","created":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T19:07:11Z","timestamp":1673032031000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case report: \u2018Photodynamics of Subependymal Giant Cell Astrocytoma with 5-Aminolevulinic acid\u2019"],"prefix":"10.3389","volume":"9","author":[{"given":"Imran","family":"Ghani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabina","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prajwal","family":"Ghimire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Istvan","family":"Bodi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ranjeev","family":"Bhangoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Vergani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keyoumars","family":"Ashkan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose Pedro","family":"Lavrador","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,1,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 world health organization classification of tumors of the central nervous system: a summary","volume":"131","author":"Louis","year":"2016","journal-title":"Acta Neuropathol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"821","DOI":"10.3389\/fneur.2019.00821","article-title":"Newly diagnosed and growing subependymal giant cell astrocytoma in adults with tuberous sclerosis Complex: results from the international TOSCA study","volume":"10","author":"Jansen","year":"2019","journal-title":"Front Neurol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1515\/revneuro-2017-0027","article-title":"The natural history of subependymal giant cell astrocytomas in tuberous sclerosis complex: a review","volume":"29","author":"Chan","year":"2018","journal-title":"Rev Neurosci"},{"key":"B4","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1111\/j.1468-1331.2009.02567.x","article-title":"Prevalence of subependymal giant cell tumors in patients with tuberous sclerosis and a review of the literature","volume":"16","author":"Adriaensen","year":"2009","journal-title":"Eur J Neurol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.pediatrneurol.2013.12.004","article-title":"Surgical treatment of subependymal giant cell astrocytoma in tuberous sclerosis complex patients","volume":"50","author":"Kotulska","year":"2014","journal-title":"Pediatr Neurol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.pediatrneurol.2013.08.017","article-title":"Subependymal giant cell astrocytoma: diagnosis, screening, and treatment. Recommendations from the international tuberous sclerosis Complex consensus conference 2012","volume":"49","author":"Roth","year":"2013","journal-title":"Pediatr Neurol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"e0180939","DOI":"10.1371\/journal.pone.0180939","article-title":"Everolimus long-term use in patients with tuberous sclerosis complex: four-year update of the EXIST-2 study","volume":"12","author":"Bissler","year":"2017","journal-title":"PLoS One"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1016\/S1470-2045(14)70489-9","article-title":"Everolimus for subependymal giant cell astrocytoma in patients with tuberous sclerosis complex: 2-year open-label extension of the randomised EXIST-1 study","volume":"15","author":"Franz","year":"2014","journal-title":"Lancet Oncol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"232561","DOI":"10.1155\/2014\/232561","article-title":"5-Aminolevulinic Acid fluorescence in high grade glioma surgery: surgical outcome, intraoperative findings, and fluorescence patterns","volume":"2014","author":"Della Puppa","year":"2014","journal-title":"Biomed Res Int"},{"key":"B10","doi-asserted-by":"publisher","first-page":"vdab047","DOI":"10.1093\/noajnl\/vdab047","article-title":"5-Aminolevulinic acid-guided resection improves the overall survival of patients with glioblastoma-a comparative cohort study of 343 patients","volume":"3","author":"Baig Mirza","year":"2021","journal-title":"Neurooncol Adv"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ons\/opz336","article-title":"The use of 5-aminolevulinic acid in low-grade glioma resection: a systematic review","volume":"19","author":"Almekkawi","year":"2020","journal-title":"Oper Neurosurg (Hagerstown)"},{"key":"B12","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1016\/j.clineuro.2013.07.016","article-title":"Aquaporin-4 in glioma and metastatic tissues harboring 5-aminolevulinic acid-induced porphyrin fluorescence","volume":"115","author":"Molina EJ","year":"2013","journal-title":"Clin Neurol Neurosurg"},{"key":"B13","doi-asserted-by":"publisher","first-page":"705","DOI":"10.3389\/fneur.2019.00705","article-title":"Clinical characteristics of subependymal giant cell astrocytoma in tuberous sclerosis Complex","volume":"10","author":"Jansen","year":"2019","journal-title":"Front Neurol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s41016-017-0077-4","article-title":"Clinical and imaging features of subependymal giant cell astrocytoma: report of 20 cases","volume":"3","author":"Mei","year":"2017","journal-title":"Chin Neurosurg Jl"},{"key":"B15","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.neucir.2017.03.002","article-title":"Fluorescence guided resection with 5-aminolevulinic acid of a pilomyxoid astrocytoma of the third ventricle","volume":"28","author":"Bernal Garc\u00eda","year":"2017","journal-title":"Neurocirugia (Astur)"},{"key":"B16","doi-asserted-by":"publisher","first-page":"e76988","DOI":"10.1371\/journal.pone.0076988","article-title":"5-Aminolevulinic Acid induced fluorescence is a powerful intraoperative marker for precise histopathological grading of gliomas with non-significant contrast-enhancement","volume":"8","author":"Widhalm","year":"2013","journal-title":"PLoS One"},{"key":"B17","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1227\/NEU.0000000000001020","article-title":"The value of 5-aminolevulinic acid in low-grade gliomas and high-grade gliomas lacking glioblastoma imaging features: an analysis based on fluorescence, magnetic resonance imaging, 18F-fluoroethyl tyrosine positron emission tomography, and tumor molecular factors","volume":"78","author":"Jaber","year":"2016","journal-title":"Neurosurg"},{"key":"B18","doi-asserted-by":"publisher","first-page":"771","DOI":"10.3171\/2014.12.JNS14391","article-title":"Quantitative fluorescence using 5-aminolevulinic acid-induced protoporphyrin IX biomarker as a surgical adjunct in low-grade glioma surgery","volume":"123","author":"Vald\u00e9s","year":"2015","journal-title":"J Neurosurg"},{"key":"B19","doi-asserted-by":"publisher","first-page":"E10","DOI":"10.3171\/2013.12.FOCUS13464","article-title":"Use of fluorescence to guide resection or biopsy of primary brain tumors and brain metastases","volume":"36","author":"Marbacher","year":"2014","journal-title":"Neurosurg Focus"},{"key":"B20","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1007\/s00701-020-04223-x","article-title":"5-ALA Fluorescence in a WHO grade I papillary glioneuronal tumour: a case report","volume":"162","author":"Lavrador","year":"2020","journal-title":"Acta Neurochir (Wien)"},{"key":"B21","doi-asserted-by":"publisher","first-page":"Page iv20","DOI":"10.1093\/neuonc\/noac200.091","article-title":"Photodynamics of subependymal giant cell astrocytoma (SEGA) with 5-aminolevulinic acid (5-ALA\/gliolan\u00a9)","author":"Ghani","year":"2022","journal-title":"Neuro-Oncol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.5772\/19788","article-title":"Intraoperative photodynamic diagnosis of brain tumors using 5-aminolevulinic acid. In: Abujamra, AL, editor. Diagnostic techniques and surgical management of brain tumors","author":"Utsuki","year":"2011"},{"key":"B23","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.3390\/jcm9082405","article-title":"Lighting up the tumor\u2014fluorescein-guided resection of gangliogliomas","volume":"9","author":"H\u00f6hne","year":"2020","journal-title":"J Clin Med"},{"key":"B24","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s10143-015-0695-2","article-title":"The role of 5-aminolevulinic acid in brain tumor surgery: a systematic review","volume":"39","author":"Ferraro","year":"2016","journal-title":"Neurosurg Rev"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1002\/cncr.24903","article-title":"5-Aminolevulinic Acid is a promising marker for detection of anaplastic foci in diffusely infiltrating gliomas with nonsignificant contrast enhancement","volume":"116","author":"Widhalm","year":"2010","journal-title":"Cancer"}],"container-title":["Frontiers in Surgery"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fsurg.2022.1065979\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T19:07:13Z","timestamp":1673032033000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fsurg.2022.1065979\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,6]]},"references-count":25,"alternative-id":["10.3389\/fsurg.2022.1065979"],"URL":"https:\/\/doi.org\/10.3389\/fsurg.2022.1065979","relation":{},"ISSN":["2296-875X"],"issn-type":[{"type":"electronic","value":"2296-875X"}],"subject":[],"published":{"date-parts":[[2023,1,6]]},"article-number":"1065979"}}